Stocks
Intra-Cellular Therapies (ITCI) ROE US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -34.6% | -68.0% | -39.1% | -23.6% | -6.50% | -6.50% | ||
| Changes by years, y/y, % | +41pp | -33pp | +29pp | +15pp | +17pp | -38.8% | |||
Intra-Cellular Therapies. ROE, %
Intra-Cellular Therapies. ROE, changes, pp
Intra-Cellular Therapies (ITCI) ROE US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | LTM ? | |||
| ROE, % | ? | -23.6% | -18.5% | -7.37% | -7.54% | -6.50% | -6.50% | |
| Changes by years, y/y, % | +14pp | +16pp | +22pp | +17pp | +17pp | |||
| Changes by quarters, q/q, % | +1pp | +5pp | +11pp | 0pp | +1pp | |||
